Newsletter
Canakinumab for Severe COVID-19, Medical Debt in the US, Novel Lipid-Lowering Therapies, and more

JAMA Editor’s Summary

Canakinumab for Severe COVID-19, Medical Debt in the US, Novel Lipid-Lowering Therapies, and more

Editors' Summary by Kristin Walter, MD, Associate Editor of JAMA, the Journal of the American Medical Association, for the issue.
July 20, 2021

Canakinumab for Severe COVID-19, Medical Debt in the US, Novel Lipid-Lowering Therapies, and more

Editors’ Summary by Kristin Walter, MD, Associate Editor of JAMA, the Journal of the American Medical Association, for the July 20, 2021 issue.

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Join Our Newsletter

Proudly supported by:

cover
What are the Early Stages of Alzheimer’s Disease? Despite significant breakthroughs in medical knowledge, Alzheimer’s disease is still shrouded in stigma and misconception. In this episode, we hear personal stories of what living with Alzheimer’s is like.